Epstein Secrets

andemic-damaged U.S. economy." The Dow ended the day 152.84 points higher at 28,363.66, the S&P 500 added 17.93 points to close at 3,453.49, and the Nasdaq climbed 21.31 points to 11,506.01. The AR (10/22, Choe, Troise, Veiga) and the Wall Street Journal (10/22, Bartholomew, Eisen, Subscription Publica

WHO study, which was not 'blinded,' meaning that participants and their doctors were aware of which treatments were being used." Bloomberg (10/22, Langreth, 4.73M) reports the approval also allows "Gilead to market the drug and talk about its benefits to doctors, nurses, and patients. That could help so

37510 day earlier." The Dow posted a record, climbing 97.31 points to 34,230.34, and the S&P 500 gained 2.93 points to close at 4,167.59 while the Nasdaq fell 51.08 points to 13,582.42. Reuters <https://www.reuters.com/business/futures-rise-growth-stocks-bounce-economic-data-eyed-2021-05-05/> (5/5),

Bloomberg <https://www.bloomberg.corn/news/articles/2021-05-05/moderna-booster-shot-bolsters-antibodies- against-variant-strains?srnd—premium> (5/5, Langreth, 3.57M) reports that Moderna published the latest results from its mid-stage vaccine trial, and it found that its COVID booster shots "gave positive

-off a day earlier." The Dow posted a record, climbing 97.31 points to 34,230.34, and the S&P 500 gained 2.93 points to close at 4,167.59 while the Nasdaq fell 51.08 points to 13,582.42. Reuters (5/5), flloomherg (5/5, Papuc, Barrett, 3.57M), and the Wall Street Journal (5/5, Ostroff, Subscription Pub

ry contact with the health system to come with the offer of a vaccine." Moderna Study Finds Vaccine Is Effective Against Variants. Bloomberg (5/5, Langreth, 3.57M) reports that Moderna published the latest results from its mid- stage vaccine trial, and it found that its COVID booster shots "gave positive

andemic-damaged U.S. economy." The Dow ended the day 152.84 points higher at 28,363.66, the S&P 500 added 17.93 points to close at 3,453.49, and the Nasdaq climbed 21.31 points to 11,506.01. The AP <https://www.usatoday.com/story/money/2020/10/22/us-stocks-flip-flop-amid-profit-reports-stimulus- talks/3

used." Bloomberg <https://www.bloomberg.cotn/news/articles/2020-10-22/gilead-virus-therapy-remdesivir-gains- approval-from-fda?srnd-premium> (10/22, Langreth, 4.73M) reports the approval also allows "Gilead to market the drug and talk about its benefits to doctors, nurses, and patients. That could help so

-off a day earlier." The Dow posted a record, climbing 97.31 points to 34,230.34, and the S&P 500 gained 2.93 points to close at 4,167.59 while the Nasdaq fell 51.08 points to 13,582.42. Reuters (5/5), Bloomberg (5/5, Papuc, Barrett, 3.57M), and the Wall Street Journal (5/5, Ostroff, Subscription Publ

ry contact with the health system to come with the offer of a vaccine." Moderna Study Finds Vaccine Is Effective Against Variants. Bloomberg (5/5, Langreth, 3.57M) reports that Moderna published the latest results from its mid-stage vaccine trial, and it found that its COVID booster shots "gave positive